Baoji Pharmaceutical Group B (02659.HK) intends to increase its holdings by Chairman Dr. Liu Yanjun.

Wisdom Financial News App News, Baoki Pharmaceutical-B (02659.HK) announced that the company has received a notification from Dr. Liu Yanjun, Chairman of the Board and member of the company's controlling shareholder group, expresses confidence in the future prospects and growth potential of the group, as well as recognition of the long-term investment value of the company. He intends to increase his shareholding in the company through open market transactions within three months from the date of this announcement. According to the relevant minimum public shareholding requirements under the listing rules, and to ensure compliance with such requirements, the maximum number of H shares that the controlling shareholder can acquire shall not exceed 38.8939 million shares.